CVS Health (CVS) PT Lowered to $57 at Leerink Partners

November 18, 2024 6:23 AM EST Send to a Friend
Leerink Partners analyst Michael Cherny lowered the price target on CVS Health (NYSE: CVS) to $57.00 (from $63.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login